Regional adrenalectomy completed by prophylactic hyperthermic intraperitoneal chemotherapy reduces the incidence of local and peritoneal recurrence after curative surgery for adrenocortical carcinoma

View at publisher Summarise with VIRAT
Authors: G Tiberio, Giovanni Casole, Deborah Cosentini, Marta Laganà, Sandra Sigala, Silvia Ministrini, Alfredo Berruti
Cited by: 0
References: 15

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

BACKGROUND: Local and peritoneal recurrence (L/PR) after curative surgery for adrenocortical carcinoma has a high incidence and negatively affects the clinical course of the disease. We retrospectively reviewed our database to investigate the role of regional surgery and prophylactic HIPEC on oncologic outcome. METHODS: Fifty-eight patients with stage II and III adrenocortical carcinoma (ACC) who underwent curative surgery were grouped according to the therapeutic approach: 11 received regional adrenalectomy and HIPEC (REGHIPEC), 18 underwent regional adrenalectomy (REGIONAL), and 29 had simple adrenalectomy (SIMPLE). The primary outcome was local/peritoneal disease-free survival (L/PDFS); secondary outcomes included overall disease-free survival (ODFS) and disease-specific survival (DSS). RESULTS: HIPEC increased surgery duration by 80 minutes and hospital stay by 3 days. Major morbidity was 27.2% in the REGHIPEC group and 5.5% in the REGIONAL group. Median post-operative follow-up was 56 months for the entire cohort. L/PR was observed in 0%, 35%, and 82% of cases in the study groups, respectively. REGHIPEC and REGIONAL groups did not reach the median L/PDFS, while the SIMPLE group had a median L/PDFS of 23 months (P < .001). Overall recurrence (including hematogenous metastases) was observed in 18%, 50%, and 86.2% of cases, respectively (P < .001). Disease-specific mortality during follow-up was 18%, 33%, and 72.4% in the three groups, respectively. REGHIPEC and REGIONAL groups did not reach the median DSS, while the SIMPLE group had a median DSS of 63 months (P = .014). CONCLUSION: HIPEC after regional adrenalectomy has decreases the incidence of local and peritoneal recurrence. If confirmed, this therapeutic strategy may change the surgical approach to stage II-III ACC.

Fields of Study & Subjects

Adrenal and Paraganglionic Tumors Intraperitoneal and Appendiceal Malignancies Renal cell carcinoma treatment

Publication details

Journal / source
European Journal of Endocrinology
Volume
194
Issue
4
Pages
482–488
Publication date
26 March 2026
Language
EN